Dewey & LeBoeuf LLP - Coleman, Timothy J.

Timothy J. Coleman Partner

Timothy J. Coleman is a partner in the firm's Litigation Department and co-chair of the White Collar Criminal Defense and Investigations Practice Group. Mr. Coleman represents corporate and individual clients in criminal and regulatory investigations, and related civil proceedings.

Most recently, Mr. Coleman has represented a leading pharmaceutical care company in connection with criminal and civil investigations by multiple United States Attorneys Offices and state attorney generals concerning allegations of healthcare fraud; a publicly traded hospital company in an investigation of alleged earnings management by the U.S. Securities and Exchange Commission; numerous corporations in connection with inquiries into the timing and other aspects of stock options grants and other executive compensation transactions; and a leading technology company in an investigation by the U.S. Department of Justice and the U.S. Securities and Exchange Commission of potential violations of the Foreign Corrupt Practices Act. Mr. Coleman also represents corporate executives and other individuals in connection with investigations of securities fraud, commodities fraud, healthcare fraud, antitrust violations and official corruption. He counsels corporate clients in connection with a variety of issues, including corporate compliance programs.

Prior to joining the firm, Mr. Coleman served for more than eight years with the U.S. Department of Justice, where he played a leading role in some of the most notable corporate fraud cases in recent times. As a senior advisor to the Department's leadership, Mr. Coleman supervised the work of federal prosecutors throughout the United States on major corporate investigations, including the investigation of Enron Corporation. Mr. Coleman was responsible for the President's Corporate Fraud Task Force, served as the Justice Department's Special Counsel for Healthcare Fraud and chaired the Attorney General's Working Group on Sentencing Policy. As an Assistant United States Attorney for the Southern District of New York for more than six years, he was the lead prosecutor on numerous major corporate investigations, including the investigations of Adelphia Communications Corp., Vivendi Universal, S.A. and Datek Securities Corporation. Mr. Coleman is an experienced trial lawyer who has handled criminal and civil cases before federal, and state courts throughout the country.

Mr. Coleman has testified before the United States Senate and House of Representatives on white collar crime issues and is a frequent public speaker on such topics as corporate compliance, internal investigations and the role of in-house counsel. Prior to entering government service, he was in private practice with Cravath, Swaine & Moore in New York. Mr. Coleman is a 1990 graduate of the Georgetown University Law Center, where he was a member of the Georgetown Law Journals . Prior to his legal career, he worked as a foreign exchange trader.

Selected Activities

American Bar Association
Association of the Bar of the City of New York
Edward Bennett Williams Inn of Court, Washington, DC
Federal Bar Council

Publications

"Corporate Cooperation," National Law Journal (May 29, 2007).
"Commodity Futures Trading Commission Issues Revised Cooperation Guidelines," BNA Securities Regulation & Law Report (May 21, 2007).
"Excesses of Corporate Prosecution Should Be Curbed" (op-ed), Financial Times (July 20, 2006).
"What Does Law Enforcement Regard as an Effective Compliance Program?," in Corporate Compliance Institute 2006, at 211 (PLI Corporate Law and Practice, Course Handbook Series No. B-1536).
"Paying the Price: New SEC Guidelines Suggest Shift in Determining Corporate Fines," GC New York/New York Law Journal ( March 27, 2006).

Speeches & Programs

ABA Securities Fraud National Institute, "Lawyers, Lawyers, Everywhere: Who Do You Represent Again?" (October 25, 2007, Washington, DC).
Sixteenth National Annual Seminar on the Federal Sentencing Guidelines, sponsored by the US Sentencing Commission and the Federal Bar Association, "The Organizational Sentencing Guidelines" (May 24, 2007, Salt Lake City).
ABA Securities Fraud National Institute, "Nuts and Bolts: Primer on SEC and DOJ Securities Fraud Prosecutions" (September 28, 2006, Washington, DC).
Federal Bar Association Criminal Law Committee Program, "Corporate Deferred Prosecutions" (September 19, 2006, Philadelphia).
PLI Advanced Corporate Compliance Institute 2006, "Investigating and Responding to Compliance Concerns" (September 18, 2006, NYC).
National Association of Corporate Directors Meeting, "Bad to Worse: Why Some Companies Survive Corporate Scandals and Others Don’t" (February 23, 2006, Washington, DC).
Ethics Officer Association Annual Business Ethics and Compliance Conference 2005, "Inside The Beltway: Shaping Corporate Governance" (October 27, 2005, San Antonio).
SEC Securities Enforcement Coordination Conference, "Working Together: Now and in the Future" (October 18, 2005, Washington, DC).
United States Senate, Finance Committee, "Medicaid Waste, Fraud And Abuse: Threatening The Health Care Safety Net" (June 29, 2005, Washington, DC).
ABA Health Care Fraud National Institute, "Enforcement Agenda for 2005" (May 19, 2005, Palm Springs).
The Cato Institute, "Deputizing Company Counsel as Agents of The Federal Government" (April 26, 2005, Washington, DC).
Fordham Law School Center for Corporate Securities & Financial Law, "Bigger Carrots and Bigger Sticks: Issues and Developments in Corporate Sentencing" (April 20, 2005, NYC).
ABA National Institute on White Collar Crime, "Evolution of Corporate Cooperation -- The Changing Relationship Between Companies and Their Employees" and "Playing Hard Ball: Tactics for the Defendant Who Still Wants to Fight" (March 3, 2005, Las Vegas).